Retired/Replaced Guidelines

AAN guidelines can be retired for any of the following reasons:

  • The technology discussed in the guideline may be outdated
  • The conclusions and recommendations in the guideline may be unsafe
  • The guideline has been replaced by a more recent publication
  • There is a lack of resources to update the guideline

Displaying 1 - 20 out of 56 guidelines found

  1. Update: NSAIDs and Other Complementary Treatments for Episodic Migraine Prevention in Adults

    April 2012

    Retired by the AAN Institute Board of Directors on September 16, 2015.

  2. The Use of Natalizumab (Tysabri) for the Treatment of Multiple Sclerosis

    September 2008

    Retired guideline.

  3. Diagnosis and Prognosis of New Onset Parkinson Disease

    April 2006

    Retired by the AAN Institute Board of Directors on March 9, 2016.

  4. Therapies for Essential Tremor

    June 2005

    Updated by "Evidence-based Guideline Update: Treatment of Essential Tremor" (June 2011).

  5. Utility of MRI in Suspected MS

    September 2003

    Retired by the AAN Institute Board of Directors on March 8, 2016.

  6. Electrodiagnostic Studies in Carpal Tunnel Syndrome

    June 2002

    Retired guideline.

  7. Steroids, Acyclovir, and Surgery for Bell's Palsy

    April 2001

    Replaced by "Update: Steroids and Antivirals for Bell Palsy" (November 2012).

  8. Evidence-based Guidelines for Migraine Headache

    September 2000

    Replaced by "Update: Pharmacologic Treatment for Episodic Migraine Prevention in Adults" (April 2012).

  9. Clinical Utility of Surface EMG

    July 2000

    Retired by the AAN Board of Directors on December 9, 2006.

  10. The Role of Corticosteroids in the Management of Acute Monosymptomatic Optic Neuritis

    June 2000

    Retired by the AAN Board of Directors on January 2007.

  11. Anticonvulsant Prophylaxis in Patients with Newly Diagnosed Brain Tumors

    May 2000

    Retired by the AAN Institute Board of Directors on June 4, 2012.

  12. Risk of Driving and Alzheimer's Disease

    January 2000

    Retired and replaced by "Update: Evaluation and Management of Driving Risk in Dementia" (April 2010).

  13. Electrodiagnostic Studies in Ulnar Neuropathy at the Elbow

    September 1999

    Retired by the AAN Institute Board of Directors on March 8, 2016.

  14. Reassessment: Vagus Nerve Stimulation for Epilepsy

    September 1999

    Replaced by 2013 publication. Reaffirmed on October 17, 2003. Supplement to "Assessment of Vagus Nerve Stimulation for Epilepsy" (July 1997).

  15. The Relationship of MS to Physical Trauma and Psychological Stress

    June 1999

    Retired guideline

  16. The Care of the Patient with Amyotrophic Lateral Sclerosis

    April 1999

    Retired by the AAN Board of Directors on November 9, 2009. Replaced by 2009 updates: "The Care of the Patient with Amyotrophic Lateral Sclerosis: Drug, Nutritional, and Respiratory Therapies" and "The Care of the Patient with Amyotrophic Lateral Sclerosis: Multidisciplinary Care, Symptom Management, and Cognitive/Behavioral Impairment".

  17. Management Issues for Women with Epilepsy

    October 1998

    Retired by the AAN Board of Directors on November 9, 2009. Replaced by 2009 updates "Management Issues for Women with Epilepsy - Focus on Pregnancy: Vitamin K, Folic Acid, Blood Levels, and Breastfeeding", "Teratogenesis and Perinatal Outcomes" and "Obstetrical Complications and Change in Seizure Frequency".

  18. Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation

    September 1998

    Replaced by "Summary of Evidence-based Guideline Update: Prevention of Stroke in Nonvalvular Atrial Fibrillation" (February 2014).

  19. Evaluation and Management of Intracranial Mass Lesions in AIDS

    January 1998

    Retired by the AAN Board of Directors on March 8, 2016.

  20. Dermatomal Somatosensory Evoked Potentials

    October 1997

    Retired on July 20, 2007.

Questions?

Email guidelines@aan.com

Call (800) 879-1960 or (612) 928-6000 (international)

Top

Footer